Imidazole → HCID 57581112, compound
Reaction equation
[NH2:1][C:2]1[CH:11]=[CH:10][C:5]([O:6][CH2:7][CH2:8]O)=[CH:4][C:3]=1[N+:12]([O-:14])=[O:13].[CH3:15][C:16]([Si:19](Cl)([CH3:21])[CH3:20])([CH3:18])[CH3:17].N1C=CN=C1>CN(C=O)C>[C:16]([Si:19]([CH3:21])([CH3:20])[CH2:8][CH2:7][O:6][C:5]1[CH:10]=[CH:11][C:2]([NH2:1])=[C:3]([N+:12]([O-:14])=[O:13])[CH:4]=1)([CH3:18])([CH3:17])[CH3:15]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
2-(4-amino-3-nitro-phenoxy)-ethanol Compound 18a (0.5 g, 2.52 mmol) was treated with TBSCl (0.42 g, 2.52 mmol) and imidazole (0.173 g, 2.52 mmol) in DMF (10 mL) at room temperature overnight. DMF was removed under vacuum and the residue was diluted with AcOEt, washed with H2O and saturated aqueous NH4Cl and dried over Na2SO4. The solvent was evaporated to dryness to provide 4-[2-(tert-butyl-dimethyl-silanyl)-ethoxy]-2-nitro-phenylamine Compound 18b (0.787 g) as a golden solid. LCMS single peak, 3.93 min, MS (ESI) m/z 313.2 (M+H+). 1H NMR (300 MHz, CDCl3) δ 7.46 (s, 1 H), 7.00 (d, 1 H, J=9.0 Hz), 6.66 (d, 1 H, J=9.0 Hz), 3.94-3.84 (m, 4 H), 0.81 (s, 9 H), −0.01 (s, 6 H).
Workup
- customDMF was removed under vacuum
- additionthe residue was diluted with AcOEt
- washwashed with H2O and saturated aqueous NH4Cl
- dry with materialdried over Na2SO4
- customThe solvent was evaporated to dryness
Sources & evidence
- ORD record
- ord-becedf3a162a4f6994eadaa3d62fe433
- Source dataset
- uspto-grants-2009_06
- Patent number
- US07541367B2
Reaction notes
Loading…